FDA wades in with guidance on CBD – and warnings over ‘deceptive’ claims

A high-level working group will explore legal pathways to market for certain CBD products, according to the US FDA – which also revealed it had sent warning letters to three companies it accused of “unfounded claims” ...

Restricted content. Do you want to read more?